Stem cells show early promise for treating type 2 diabetes

Mar 29, 2009 By Fred Tasker

Human trials under way at the University of Miami and other hospitals in Europe, Asia and Latin America using immature adult stem cells are showing promise for people with type 2 diabetes.

In a University of Miami clinical trial recently published in the online journal , 25 patients achieved better production, lower blood-sugar levels and reduced need for insulin injections.

In the trial, still in its pilot stage, doctors extracted immature adult from the patients' own bone marrow, purified and concentrated them, and injected them into arteries near the pancreas. They then put the patients into hyperbaric oxygen chambers like those used for divers with decompression sickness - also called the "bends" - and subjected them to 10 hours of pure oxygen at 2.4 times the atmospheric pressure at ground level.

Researchers believe the high-pressure oxygen pulled extra stem cells from the patients' bone marrow, adding to the stem cells injected near the pancreas. They say the immature stem cells developed into pancreatic cells, regenerating the pancreas's ability to produce natural insulin.

"This could be very important," says Dr. Camillo Ricordi, director of the Cell Transplant Center and the Diabetes Research Institute at University of Miami. "It could be an improved treatment for diabetes, substantially ameliorating type 2 and preventing the complications of the disease."

Nearly 24 million people in the U.S., or 8 percent of the population, have diabetes, which can cause problems for the eyes, kidneys, nerves and heart, according to the Centers for Disease Control and Prevention.

Ricordi cautioned that the optimistic findings come from small pilot studies involving only dozens of patients, and three to four more years of research are needed before practical treatments might start.

"We always have to avoid hype and be careful not to put too much hope in pilot trials," Ricordi said. "But the first results are really promising."

Two more successful trials over three or four years would be needed before the FDA might approve the treatment for the public. The studies, coordinated by University of Miami's Diabetes Research Institute, will also take place at the Karolinska Institutet in Stockholm, Stem Cell Argentina in Buenos Aires and other institutions.

___

(c) 2009, The Miami Herald.
Visit The Miami Herald Web edition on the World Wide Web at www.herald.com/
Distributed by McClatchy-Tribune Information Services.

Explore further: Vegetable oil ingredient key to destroying gastric disease bacteria

add to favorites email to friend print save as pdf

Related Stories

Studies test new approaches to islet transplantation

May 01, 2008

Researchers from 11 medical centers in the United States, Canada, Sweden, and Norway have begun testing new approaches to transplanting clusters of insulin-producing islets in adults with difficult-to-control type 1 diabetes. ...

Stem cell breakthrough offers diabetes hope

Apr 03, 2008

Scientists have discovered a new technique for turning embryonic stem cells into insulin-producing pancreatic tissue in what could prove a significant breakthrough in the quest to find new treatments for diabetes.

Stem cells to be injected into the heart

Aug 26, 2005

The University of Pittsburgh Medical Center will begin a clinical trial to determine the feasibility of injecting a patient's own stem cells into the heart.

Elusive pancreatic stem cells found in adult mice

Jan 24, 2008

Just as many scientists had given up the search, researchers have discovered that the pancreas does indeed harbor stem cells with the capacity to generate new insulin-producing beta cells. If the finding made in adult mice ...

Recommended for you

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.